Munich, 31 January 2024. At Germany's leading telemedicine platform TeleClinic, Julian Dittel, Chief Operating Officer (COO), took over the management of the company as Co-Managing Director at the beginning of the year alongside the previous Managing Director Benedikt Luber, Chief Marketing Officer (CMO). The previous CEO, Max Müller, will leave TeleClinic at his own request on 31 March 2024 to pursue new professional challenges.

As a long-standing co-managing director and former COO, Max Müller became CEO of TeleClinic in 2022. "As CEO, Max Müller helped make TeleClinic the leading technical platform for online doctor visits in Germany. Against the general market trend, he expanded the company into a rapidly growing telemedicine provider and successfully led it into the profit zone. I am extremely grateful to Max Müller for this and wish him all the best for the future," says Walter Hess, CEO of DocMorris.

Müller´s tasks and functions will be assumed by the two Co-Managing Directors of TeleClinic, Benedikt Luber and Julian Dittel. Both have been very familiar with the operational telemedicine business and the company's strategic goals for many years. "We are delighted to have two such experienced managers at the helm of TeleClinic, who have in-depth knowledge and proven expertise. Both will ensure continuity and make a decisive contribution to successfully shaping the future of TeleClinic and continuing its growth," continued Hess.

About TeleClinic:
TeleClinic GmbH is Germany's most popular telemedicine platform. Through the TeleClinic platform, patients are telemedically treated by an experienced, Germany-based physician within minutes. Medical certificates, prescriptions, and doctor's letters are sent directly to patients' smartphones. Prescriptions can be redeemed nationwide at local pharmacies or online pharmacies.

For more information, please www.teleclinic.com

Press contact TeleClinic:
Torben Bonnke
Director Communications
pr@teleclinic.com
Mobile: +49 171 864 888 1